(1) The term "poor-quality medicines" is something of a catch-all. It includ

游客2023-10-21  15

问题     (1) The term "poor-quality medicines" is something of a catch-all. It includes "substandards, " medicines that have had inadequate quality control or that have degraded from improper storage or the passage of time. And it includes falsified medicines—fakes that claim to be what they are not. These may not be made by the manufacturer whose name is on the package, and they may not contain the stated ingredients in the stated quantities.
    (2) Poor-quality medicines might not work. Like those peddled by Peter Gillespie, who was jailed for introducing 72000 packets of falsified medicines into the UK’s distribution system. 25000 packets reached pharmacies and were given to patients. These knockoff tablets were used to treat heart disease, pancreatic cancer and mental illnesses, and had none or only part of the active ingredient they were supposed to contain. This meant that those people’s illnesses were left to take their course.
    (3) Poor-quality medicines can kill you if you take them. As happened with Thomas Rybinski, a 56-year-old autoworker from Tennessee, USA, who got an injection for his back pain. He fell ill and died because the medicine had contaminants that caused fungal meningitis. The batch of medicine, originating in a New England pharmacy with close to no quality control, ended up causing severe infections in nearly 800 people across the USA, killing 64 of them.
    (4) Poor-quality medicines can kill you even if you don’t take them. Antimicrobial drugs (including antibiotics and antivirals) that have too little active ingredient are generally accepted to help disease-causing bugs evolve so that they develop resistance to treatment even with good-quality antimicrobials. And then these bugs spread. Ramanan Laxminarayan is the director of the Center for Disease Dynamics, Economics and Policy in Washington, DC. He says that with some drugs, like statins or arthritis drugs, the effects of poor quality are confined to those taking them. But with antimicrobials, inappropriate use reduces their effectiveness for everyone else. "If there’s misuse in South Asia, then everyone is affected. It’s a problem that comes up when people act in ways that don’t take into account the effects of what they are doing on everyone else, " he says.
    (5) "It’s really no different from climate change, " says Laxminarayan. "Either in terms of potential global impact, or in the fact that everyone needs to be working together to solve the problem."
    (6) The factors that speed up the development of antimicrobial resistance—high rates of infections, the overuse and misuse of antimicrobials, poor sanitation, poor-quality medicines—are more common in low- and middle-income countries, which means that so is resistance. But microbes know no boundaries, and they travel easily across the world, in foodstuffs being exported and in the bodies of humans. And often, resistant microbes can transfer genetic material to each other to become even more dangerous to humans.
    (7) The result: infections that were simple to cure, gonorrhoea for example, are back with a vengeance. Conditions like tuberculosis and HIV are getting harder to treat. In the future, routine surgery or cancer treatment could become risky. There is a real danger of returning to a time where any one of us, anywhere in the world, could pick up such an infection and find that medicine is powerless to save us from dying. (本文选自 mosaicscience. com) [br] We can know from Para. 2 that Peter Gillespie________.

选项 A、was in charge of the UK’s distribution system
B、was punished for selling falsified medicines
C、manufactured about 25000 packets of fake medicines
D、suffered from serious pancreatic cancer

答案 B

解析 细节题。由题干中的PeterGfllespie定位到原文第二段。本段第二句提到,彼得.吉莱斯皮将7.2万包伪造药品引入英国分销系统,并因此入狱。由此可知,彼得.吉莱斯皮因售卖假药而受到了惩罚,故本题答案为B。由本段第二句可知,彼得.吉莱斯皮是将伪造药品引入英国分销系统,并非制造伪造药品,文中未提及他是否负责英国分销系统,故可以排除A和C;本段第四句提到,这些仿制药片用于治疗心脏病、胰腺癌和精神疾病,并没有提到彼得.吉莱斯皮是否患有胰腺癌,故可以排除D。
转载请注明原文地址:https://tihaiku.com/zcyy/3118598.html
最新回复(0)